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A B S T R A C T
The metastasis cascade is complex and comprises several stages including local invasion into surrounding tissue,
intravasation and survival of tumour cells in the circulation, and extravasation and colonisation of a distant site.
It is increasingly clear that these processes are driven not only by signals within the tumour cells, but are also
profoundly inﬂuenced by stromal cells and signals in the tumour microenvironment. Amongst the many cell
types within the tumour microenvironment, immune cells such as lymphocytes, macrophages and neutrophils
play a prominent role in tumour development and progression. Neutrophils, however, have only recently
emerged as important players, particularly in metastasis. Here we review the current evidence suggesting a
multi-faceted role for neutrophils in the metastatic cascade.
1. Introduction
Metastasis, the systemic spread and establishment of foci of cancer
cells within distant organ systems, is the cause of death in the majority
of cancer patients, with survival rates alarmingly low for those diag-
nosed with metastatic disease (Steeg, 2016). In order to establish dis-
tant metastases, cancer cells must successfully navigate a sequence of
challenges, which together form the metastatic cascade. These include:
primary tumour progression with local tissue invasion; basement
membrane and endothelial transmigration (vascular invasion); in-
travascular dissemination; vascular arrest and extravasation leading to
the establishment of micrometastases; and ﬁnal outgrowth to form
macrometastases (Nguyen et al., 2009). At each step of this complex
process, cancer cells must also remain capable of evading immune
surveillance, recognition, and killing.
The complexity of the metastatic cascade described above is easily
matched by the complexity and diversity of the cellular components
that are recruited and collectively form the tumour microenvironment.
These recruited cells and the factors they produce are not only central
to the continued growth and viability of the primary tumour, but are
also increasingly recognised as vital components that facilitate the
metastatic spread of neoplastic cells (Joyce and Pollard, 2009).
Amongst the many constituent lineages of stromal cells within the tu-
mour microenvironment, innate and adaptive leukocytes such as mac-
rophages, neutrophils, and lymphocytes play a prominent role in tu-
mour development, growth, metastasis, and ongoing immune evasion
(Joyce and Pollard, 2009; Nguyen et al., 2009).
Of these leukocyte subsets, much attention has been given to tu-
mour associated macrophages (TAMs) and the role that they play
supporting tumour progression (Noy and Pollard, 2014). Increasingly
however another leukocyte population, the neutrophil, has been re-
ceiving attention due to the prominent role it plays, particularly in
metastasis. Indeed we and others have highlighted the signiﬁcant and
central role that neutrophils play in the establishment of distant me-
tastases in a number of animal models of cancer (Coﬀelt et al., 2015;
Park et al., 2016; Pekarek et al., 1995; Shojaei et al., 2007; Spicer et al.,
2012; Steele et al., 2016; Wu et al., 2015; Yamamoto et al., 2017).
Interestingly, this important role highlighted in in vivo models, is mir-
rored in the clinical setting with ever more studies, in a multitude of
human cancers, linking peripheral neutrophil counts and/or neutrophil
to lymphocyte ratio (NLR) with poor prognosis and by extension me-
tastasis (Aliustaoglu et al., 2010; Jung et al., 2011; Roxburgh et al.,
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Neutrophils classically deﬁned by their nuclear morphology and
tinctorial aﬃnity are the predominant leukocyte in the peripheral blood
of humans (Coﬀelt et al., 2016). They play a central role in host defence
against infection due to their ability to perform phagocytosis, produce
cytokines and reactive oxygen species, which can promote inﬂamma-
tion, and, through degranulation, to release the contents of their
granules into the inﬂammatory exudate. Importantly however, the
classic view of the neutrophil, as a short-lived, innate “ﬁrst-responder”
is rapidly changing and the true complexity of their function is in-
creasingly but incrementally coming to light.
Granulopoiesis occurs within the bone marrow in man, though
during foetal development and in certain pathological processes it may
also occur in sites outside the bone marrow. When this is the case, it
most commonly occurs within the spleen and liver, and is referred to as
extramedullary haematopoiesis. In rodents, particularly mice, extra-
medullary haematopoiesis is also commonly observed as a normal
component of the splenic red pulp. Numerous factors are known to play
a role in driving and modulating neutrophil production, however, the
key factor central to this process is granulocyte-colony stimulating
factor (G-CSF) (Lieschke et al., 1994). Once granulopoiesis is complete,
mature neutrophils are released from the bone marrow as terminally
diﬀerentiated eﬀector cells. The bone marrow however retains a mar-
ginal pool of mature, terminally diﬀerentiated neutrophils, ready for
release in cases of increased demand due to inﬂammatory stimuli. In
cases of severe inﬂammation, demand outstrips supply and this pool
becomes depleted. In such instances immature neutrophils, with char-
acteristic band/horseshoe or ring shaped nuclei, will begin to be re-
leased from the bone marrow niche, a so called “left-shift”. Though this
inﬂammatory “left-shift” is commonly seen in severe bacterial infec-
tions, it is also seen frequently in cases of cancer (Sagiv et al., 2015).
Unsurprisingly therefore, in cancer, it has been shown that numerous
factors involved in stimulating granulopoiesis, neutrophil release, and
chemotaxis are produced directly by neoplastic cells, or indirectly
through their induced production in other stromal cells. These factors
include G-CSF, GM-CSF, CXCL1, CXCL2, CXCL5, CXCL8 and CCL3
(Dumitru et al., 2013; Mishalian et al., 2017; Sagiv et al., 2015).
As with macrophages, tumour associated neutrophils (TANs) have
been shown to be capable of polarisation into either an anti-tumouri-
genic “N1” phenotype or, in response to TGFβ, a pro-tumorigenic “N2”
phenotype (Fridlender et al., 2009; Shaul and Fridlender, 2017). This
perhaps simpliﬁed classiﬁcation is based on the context-dependent
activation status of these neutrophils as evidenced by the expression of
various surface markers, cytokines, and their immunosuppressive ac-
tivity. “N1” neutrophils exhibit increased cytotoxicity and reduced
immunosuppressive ability through the production of TNFα, Fas, ICAM-
1, and ROS and through decreased arginase expression. “N2”
neutrophils in contrast express high levels of arginase, MMP-9, VEGF,
and numerous chemokines (e.g. CXCL4, CCL2 and CCL5) (Fridlender
et al., 2009). Frustratingly, “N1” and “N2” neutrophils are both char-
acterised, in mice, by the cell surface expression of CD11b and Ly6G.
Indeed the expression of these markers is also shared by another po-
pulation of myeloid cells, granulocytic myeloid-derived suppressor cells
(gMDSCs), which are deﬁned by their immunosuppressive activity
(Coﬀelt et al., 2016; Fridlender et al., 2012). With the recognition of the
complexity of their role, it has become apparent that the simplicity by
which neutrophils had been previously deﬁned has been eroded. In-
deed, instead of the simple innate “foot soldier”, a heterogeneous po-
pulation of cells with signiﬁcant functional plasticity has been un-
covered. In fact, due to the often shared cell morphology and the
overlap of expression of these cell surface markers between diﬀerent
functional groups, no easily deﬁned lines exist which clearly distinguish
between neutrophils, TANs (“N1” and “N2”), and gMDSCs (Coﬀelt
et al., 2016; Fridlender et al., 2012). Instead, these cell populations
almost certainly represent granulocytic myeloid cells presenting along a
continuous range of diﬀerentiation, maturity, and activation status. In
this review we will therefore highlight the roles that this spectrum of
granulocytic cells play in tumour progression and metastasis.
2. Neutrophils and the metastatic cascade
2.1. Early metastatic cascade – tumour cell invasion
Although, as highlighted in other recent reviews, the roles that
neutrophils play in supporting metastasis are likely weighted towards
the earlier stages of the metastatic cascade, a growing body of literature
increasingly points towards neutrophils playing important roles in all
stages of metastasis (Coﬀelt et al., 2016, 2015; Cools-Lartigue et al.,
2013; Spicer et al., 2012). Neutrophils perform numerous roles within
the primary tumour that promote progression and metastasis (Fig. 1).
One signiﬁcant role, likely vital within the primary tumour and beyond,
is the promotion of the invasive behaviour of tumour cells, a behaviour
which is fundamental to any tumour attempting to progress to malig-
nancy. Neutrophils can inﬂuence this behaviour due to their ability to
produce and release a wide variety of proteins, in particular serine
proteases, into the extracellular environment. These proteases are well
established in their ability to degrade a variety of structural compo-
nents of the extracellular matrix (ECM). Indeed, neutrophils have been
suggested through the production of MMP-8 and MMP-9, Cathepsin G,
and proteinase-3, to promote tumour cell invasion and migration
(Benson et al., 2012; Dumitru et al., 2013). MMP-8, also known as
neutrophil collagenase, degrades type I, II, and III collagen. As ﬁbrillar
collagens these collagen subtypes are central constituents of the ECM
and represent a signiﬁcant barrier to tumour invasion. In contrast,
Fig. 1. The role of neutrophils in the early metastatic cascade – primary
tumour progression and invasion.
NE, neutrophil elastase; Arg1, arginase 1; TGFβ, Transforming growth
factor beta; EMT, epithelial-mesenchymal transition; Zeb1, Zinc ﬁnger E-
box-binding homeobox 1; Twist, Twist-related protein 1; MMP, matrix
metalloproteinase; ECM, extracellular matrix; VEGF, Vascular endothelial
growth factor; HOCL, Hypochlorous acid; TIMP, tissue inhibitor of me-
talloproteinases; ADAMs, a disintegrin and metalloproteinase; G-CSF,
Granulocyte-colony stimulating factor; CXCL, Chemokine (C-X-C motif)
ligand; CCL, Chemokine (C-C motif) ligand; VE-cadherin, vascular en-
dothelial cadherin.
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MMP-9 degrades a number of ECM proteins, but most importantly type
IV collagen, which is the main constituent of the basement membrane
through which tumour cells must pass in order to progress from car-
cinoma-in-situ to outright carcinoma. In a murine model of pancreatic
ductal adenocarcinoma, neutrophils were found to be the major cell
group producing MMP-9 and strikingly these neutrophils were pre-
dominantly present at the invasive fronts of metastatic tumours (Benson
et al., 2012). Interestingly in infectious inﬂammatory conditions neu-
trophil entry into tissues relies on the production of MMP-9 by neu-
trophils which is induced in response to Cxcl2 signalling resulting from
crosstalk between tissue resident and helper macrophages (Schiwon
et al., 2014).
Although, as highlighted above, these serine proteases are classi-
cally produced by neutrophils, it has also been noted that neutrophils
are capable of inducing the expression of a number of these proteins in
tumour cells themselves. Indeed, in a murine orthotopic model of breast
cancer, it has been demonstrated that the interaction between neu-
trophils and tumour cells results in production of large quantities of
MMP-12 and MMP-13 (Yu et al., 2016). In this setting the inﬂux of
neutrophils is in response to CCR2 and CXCR2 ligands produced by
mesenchymal stromal cells in response to TNFα produced by the tu-
mour cells. Interestingly the functions of these MMPs mirror those of
MMP-8 and MMP-9 mentioned previously. MMP-12 degrades elastin
another component of the ECM and also a vital structural component of
vascular walls; whilst MMP-13, mirroring the function of MMP8, is able
to degrade type I, II, and III collagen.
Though neutrophils are capable of producing and inducing the
production of numerous serine proteases, an additional layer of com-
plexity is added by the fact that many, though not all, of these proteases
are produced and secreted in an inactive form and must be activated in
order to fulﬁl their potential. This again is a function which the neu-
trophil is capable of performing through the production of hypo-
chlorous acid (HOCL) by neutrophil-derived myeloperoxidase (Larco
et al., 2004). HOCL has been shown to activate MMP proenzymes (in-
cluding MMP-2, MMP-7, MMP-8, and MMP-9) either directly via oxi-
dation or indirectly through conformational change allowing activation
by other neutrophil-derived proteases, such as neutrophil elastase
(Larco et al., 2004). HOCL is also able to inactivate tissue inhibitor of
metalloprotease 1 (TIMP-1) and thus maintain the activity of MMPs and
distintegrin-metalloproteinases in the ECM (Larco et al., 2004).
Serine proteases, particularly MMP-9, also play a vital role in trig-
gering the “angiogenic switch” during tumour progression, as observed
in a murine model of pancreatic endocrine carcinogenesis (Nozawa
et al., 2006). The mechanism by which MMP-9 contributes to the
turning on of this “angiogenic switch” is likely through the indirect
release of ECM-bound factors such as vascular endothelial growth
factor (VEGF) (Nozawa et al., 2006). In addition to servicing the me-
tabolic demands of the tumour, this induced angiogenesis likely has
wider ranging eﬀects. One such eﬀect is the increase in size and per-
missive nature of the vascular window allowing tumour cell in-
travasation and therefore dissemination. Indeed neutrophils have been
shown, through the delivery of MMP-9 into the tumour microenviron-
ment, to support the formation of pro-metastatic vasculature in trans-
plant models (Deryugina et al., 2014). Additionally neutrophil-derived
MMP-9 can increase neoplastic cell intravasation secondary to the in-
duction of angiogenesis (Bekes et al., 2011).
In addition to the production of factors that modulate the ECM,
neutrophils can also promote epithelial to mesenchymal transition
(EMT) in tumours via a number of mechanisms. Hu et al. showed that
neutrophil-derived TGFβ is in part able to cause EMT in pulmonary
adenocarcinoma cells through the downregulation of E-cadherin and
upregulation of vimentin expression, and is associated with the en-
hanced migration of tumour cells in vitro (Hu et al., 2015). Neutrophil
elastase is also capable of contributing to the process of neutrophil-
induced EMT. Indeed, co-culture of pancreatic cancer cells results in
tumour cell upregulation of TWIST and downregulation of keratins, two
markers of EMT. This was shown to be dependent on neutrophil elas-
tase, which the authors suggest likely resulted in EMT due to the in-
duced loss of cell–cell contact. In the same study it was shown that the
level of tumour neutrophil inﬁltration strongly correlated with nuclear
β-catenin and ZEB-1 expression in cases of human pancreatic ductal
adenocarcinoma supporting the notion of neutrophil-induced EMT in
clinical samples (Grosse-Steﬀen et al., 2012). In a separate study,
neutrophil inﬁltration at the invasive front, an area commonly asso-
ciated with EMT, was shown to be a signiﬁcant independent predictor
of lymph node metastasis in patients with colorectal cancer (Akishima-
Fukasawa et al., 2011).
Interestingly, limited evidence also points towards neutrophil-pro-
duced growth factors forming gradients resulting in the concentration-
dependent migration of tumour cells particularly at the invasive front
(Wislez et al., 2003). Finally in a zebraﬁsh xenograft model, which
allows the unparalleled ability to image tumour cells navigating the
entirety of the metastatic cascade, He et al. revealed that neutrophils
through normal migratory processes were unwittingly leaving tracks
within the collagen matrix which allowed tumour cells to easily invade
and form micrometastases although it remains to be conﬁrmed whether
this mechanism plays a role in clinical metastasis (He et al., 2012).
Neutrophils have also been shown, in a contact-dependent manner,
to increase hepatocellular carcinoma cancer cell migration. In this
context IL-17 production within the tumour resulted in the chemo-at-
traction of neutrophils, and contact-dependent signalling between
hyaluronan on tumour cells and TLR4 on neutrophils. This activated
PI3K/Akt signalling in neutrophils resulting in increased longevity and
a contact-dependent increase in cancer cell motility (Wu et al., 2011).
The increase in longevity in this system was at least in part due to
upregulation of the anti-apoptotic protein Mcl-1 and downregulation of
the pro-apoptotic protein Bax. Thus, the manner by which neutrophils
may inﬂuence invasion may either be through secreted factors or
through direct cell-to-cell contact with tumour cells (Wu et al., 2011).
2.2. Intermediate metastatic cascade – intracellular survival of tumour cells
Once within the vasculature, tumour cells have entered a com-
pletely new and hostile environment. Indeed the level of hostility that
this environment poses was beautifully demonstrated in a study by
Fidler, which showed that less than one in every hundred metastatic
tumour cells survives to successfully form a metastasis (Fidler, 1970).
The reason for this attrition is that tumour cells must cope with nu-
merous previously unencountered factors such as; increased shear
forces, the absence of cell–cell and cell-ECM interactions, and the pre-
sence of circulating leukocytes (particularly Natural Killer (NK) cells).
As mentioned previously, given that neutrophils are the predominant
circulating leukocyte in man, it is perhaps unsurprising that studies are
beginning to show that they may contribute to tumour cell survival
within the circulation and therefore successful completion of the me-
tastatic cascade (Fig. 2).
Loss of cell–cell and cell-ECM contact, as alluded to above, is a
signiﬁcant challenge for malignant cells entering the circulation. There
are a number of ways in which metastatic cells might overcome this
obstacle, one of which is by avoiding it altogether through cell clus-
tering and the formation of neoplastic cell aggregates. Indeed cell
clustering has been shown to promote tumour cell survival and me-
tastasis (Choi et al., 2015; Fabisiewicz and Grzybowska, 2017). Though
unproven in vivo it is tempting to speculate that this may be a process
enhanced by intravascular neutrophils given that neutrophils have been
shown to promote breast cancer cell clustering in vitro, in a Cathepsin G-
dependent manner (Morimoto-Kamata et al., 2012), and aggregation of
colorectal carcinoma cells via binding of sialyl Lewis (x) on tumour cells
to L-selectin, CD11a, and CD11b on neutrophils (Jadhav et al., 2001).
Tumour cells within the circulation are also exquisitely exposed to
recognition and destruction by both the innate and adaptive immune
system. Depending on their activation status it is known that
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neutrophils may function in an immune suppressive manner (Fridlender
et al., 2009). Therefore given their presence within the peripheral cir-
culation it is unsurprising that they have been shown to play a role in
protecting tumour cells from leukocyte-mediated recognition and
killing. One population of leukocytes present within the circulation are
NK cells, which represent a population of innate cytotoxic lymphocytes
that play a vital role in the immune surveillance and destruction of
cancer cells both in the periphery and within the circulation (Morvan
and Lanier, 2015). Spiegel and colleagues have elegantly shown that
neutrophils mobilised by tumours impair NK cell function, thus in-
creasing intraluminal tumour cell survival (Spiegel et al., 2016). In this
study they showed that subcutaneous growth of a highly metastatic
mammary cancer cell line (4T1) increased the incidence of metastasis of
a rarely metastatic cell line (D2A1) growing subcutaneously in the
contralateral ﬂank. The authors were also able to increase the meta-
static capability of D2A1 cells by inducing increased expression of G-
CSF in the tumour cells. This process of metastasis however relied on
the presence of neutrophils, as when neutrophils were depleted by 1A8
antibody treatment, metastasis was signiﬁcantly decreased. Interest-
ingly, when injected intravenously in high numbers, D2A1 cells were
capable of lung colonisation, however, this process was again aided by
either administration of G-CSF or 4T1-induced neutrophilia. Given the
intravenous delivery of cells in this system these ﬁndings pointed to-
wards neutrophils playing a pro-survival role post-intravasation. In-
deed, Spiegel and colleagues were able to show that neutrophils in-
crease short-term retention of circulating tumour cells within the
pulmonary vasculature due to decreased clearance following injection.
Through NK cell depletion they were able to show that NK cell killing
was the process central to the clearance of circulating tumour cells and
that this was successfully inhibited by G-CSF-induced neutrophils. This
reduction in NK cell-mediated metastatic cell killing was not due to
decreased numbers of circulating NK cells but due to a decrease in their
ability to respond to signalling through their cell surface receptors and
become functionally activated (Spiegel et al., 2016). Other studies
support these ﬁndings, indeed, Zhang et al. have shown through co-
culture and in vivo experiments that TANs are able to prevent the up-
regulation of membranous CD69, a marker of leukocyte activation
(Zhang et al., 2015). Thus, there is growing evidence that neutrophils
can inﬂuence the metastatic cascade in part by promoting intravascular
survival through the induced suppression of leukocyte activation.
2.3. Intermediate metastatic cascade – extravasation
Having survived the hostile intravascular environment, metastatic
tumour cells now face the same challenge faced by leukocytes when
trying to marginate and transmigrate from the vessel. This is a sig-
niﬁcant challenge as cells within the vasculature attempting to adhere
to the endothelium experience signiﬁcant shear stresses that must be
overcome if the cells are to complete the process of transmigration and
successfully exit the vessel. Neutrophils again have been shown to play
a signiﬁcant role in these processes both directly and indirectly (Fig. 2).
A number of studies utilising in vivo metastasis models and intravital
microscopy have provided direct evidence of neutrophil co-localisation
with tumour cells (McDonald et al., 2009; Spicer et al., 2012). In this
context they showed that neutrophils were necessary for the formation
of metastases through the facilitation of Lewis lung carcinoma cell
adhesion to liver sinusoidal endothelium, which was dependent on
neutrophil CD11b/Mac-1 and selectin expression (McDonald et al.,
2009; Spicer et al., 2012). Numerous others studies have also demon-
strated the role that neutrophils play in aiding cancer cell adhesion to
the endothelium in metastatic sites. In these studies similar selectins
were also involved, as were CD18 and Galectin 3 on neutrophils, ICAM-
1 expression on endothelium, and T-Antigen expression on neoplastic
cells (Dong et al., 2005; Huh et al., 2010; Liang and Dong, 2008;
Reticker-Flynn and Bhatia, 2015). Disrupting these interactions not
only decreased tumour cell adherence to the vascular endothelium but
also reduced neutrophil-mediated extravasation of the tumour cells,
conﬁrming the importance that these interactions play in leading to
establishment of metastases (Huh et al., 2010). It remains to be de-
termined whether the role of the neutrophil is to locally activate the
endothelium, or whether the neutrophil must directly interact si-
multaneously with the metastatic tumour cell and endothelium to form
a complex capable of triggering arrest and adhesion to the endothelium,
and subsequent transmigration.
In addition to the surface expression of selectins and integrins that
aid in the endothelial arrest and adhesion of cancer cells, neutrophils
have also been shown to cause vascular arrest via the production of
neutrophil extracellular traps (NETs) (Cools-Lartigue et al., 2013;
Fig. 2. The role of neutrophils in the late stages of
the metastatic cascade – intravascular dissemination,
extravasation, and metastasis growth.
NETs, neutrophil extracellular traps; MMP, matrix
metalloproteinase; ICAM-1, intercellular adhesion
molecule 1; RAGE, receptor for advanced glycation
endproducts; TLR, toll-like receptor; IRS-1, insulin
receptor substrate 1; MET, mesenchymal-epithelial
transition; IL-1β, interleukin 1 beta; MAPK, mitogen-
activated protein kinase signalling; NF-κB, nuclear
factor kappa-light-chain-enhancer of activated B
cells; PI3K, Phosphatidylinositol-4,5-bisphosphate 3-
kinase signalling.
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Najmeh et al., 2017; Tohme et al., 2016). NETs are extracellular web-
like structures composed predominantly of neutrophil-derived DNA
that complexes with a wide variety of neutrophil-derived proteins in-
cluding a number of the serine proteases discussed previously (Park
et al., 2016). NETs are produced in response to a variety of in-
ﬂammatory cues and it has also been shown that NET production is
increased within tumours due to hypoxia (Cools-Lartigue et al., 2013;
Erpenbeck and Schön, 2016; Tohme et al., 2016). Using intravital
imaging, Park et al. conﬁrmed the presence of NET-like structures
surrounding 4T1 breast cancer cells within the vasculature of the lung,
and importantly also demonstrated the presence of NETs in clinical
samples of breast cancer (Park et al., 2016). The importance of the role
that NETs play in metastasis has also been demonstrated by a number of
studies in which prevention of NET formation or promoting NET de-
gradation via DNase I was able to prevent metastasis in a variety of in
vivo tumour models (Cools-Lartigue et al., 2013; Najmeh et al., 2017;
Park et al., 2016; Tohme et al., 2016). Interestingly, given the im-
portance of cell adhesion molecules in vascular arrest, Najmeh et al.
also showed that β1-integrin on both NETs and cancer cells is vital for
the adhesion of cancer cells to NETs in vivo (Najmeh et al., 2017).
Additional in vitro experiments tantalisingly point to cancer cell inter-
actions with NETs resulting in increased cancer cell invasion and mi-
gration which may further aid cancer cell extravasation once vascular
arrest has been achieved (Cools-Lartigue et al., 2013; Park et al., 2016;
Tohme et al., 2016). Intriguingly given that NETs are primarily com-
posed of DNA it has also been shown that NETs are capable of activating
toll-like receptor 9 (TLR9) on colorectal cancer cells and in so doing
promote cellular growth, proliferation, migration, and invasion via
activation of MAPK signalling (Tohme et al., 2016).
In addition to the increased invasive and migratory behaviours in-
duced by tumour cell interactions with NETs, neutrophils have also
been shown to facilitate cancer cell extravasation via a number of other
mechanisms. Indeed, Spiegel et al. showed that neutrophils aid tumour
cell extravasation via endothelial activation elicited by neutrophil-de-
rived IL-1β, as well as in a manner dependent on neutrophil-derived
MMP-8 and MMP-9 (Spiegel et al., 2016). MMP-9 may play a central
role in the mechanisms by which neutrophils aid tumour cell extra-
vasation as other studies have similarly found that loss of MMP-9 sig-
niﬁcantly impairs metastasis (Yan et al., 2010). For example, Yan et al.,
demonstrated that loss of MMP-9 results in vascular normalisation in
the pre-metastatic lungs of mammary tumour-bearing mice, with in-
creased coverage of vessels by alpha smooth muscle actin-positive cells
and formation of VE-cadherin junctions. These ﬁndings suggest that in
the metastatic setting, neutrophil-derived MMP-9 is functioning to
promote the formation of abnormal vasculature with decreased pericyte
and smooth muscle coverage and disrupted inter-endothelial junctions
(Yan et al., 2010).
2.4. Late metastatic cascade – metastatic outgrowth
Upon successful extravasation metastatic cells again ﬁnd themselves
in a novel environment and must rely on a wide variety of mechanisms
to stimulate their growth and survival. In this setting it is increasingly
established that metastatic cells land within a pre-established and fa-
vourable pre-metastatic niche (Peinado et al., 2017). Neutrophils play a
central role in this niche and their presence before the arrival of tumour
cells within metastatic sites has been repeatedly demonstrated and
occurs in response to a variety of primary tumour-derived factors
(Fig. 2). Cxcl1 produced by tumour-associated macrophages in response
to tumour-derived VEGF-A has been shown to result in the Cxcr2-de-
pendent accumulation of neutrophils within the pre-metastatic niche in
a colorectal cancer model (Wang et al., 2017). We, and others, have
also shown that Cxcr2-dependent neutrophil accumulation in the pre-
metastatic liver is required for pancreatic cancer metastasis (Steele
et al., 2016). Additionally, TIMP-1 has also been shown to contribute to
the formation of the pre-metastatic niche in the liver via induction of
hepatic SDF-1 resulting in Cxcr4-dependent chemotaxis of neutrophils
into the hepatic parenchyma (Seubert et al., 2015). Exosomal RNAs
from lung or melanoma tumour cells can also result in the chemo-at-
traction of neutrophils into the pre-metastatic niche via the TLR-3
signalling-promoted secretion of chemokines such as Cxcl1, Cxcl2,
Cxcl5, and Cxcl12 (Liu et al., 2016).
Within the pre-metastatic niche neutrophils may perform a variety
of pro-metastatic functions. For example, neutrophils have been shown
to promote metastatic growth by inducing mesenchymal-to-epithelial
transition (MET) and stimulating mammary cancer cell proliferation
(Ouzounova et al., 2017). This ﬁnding is of note when we consider that
neutrophils may also promote EMT in the context of the primary tu-
mour invasive front. Neutrophil elastase has also been shown, through
degradation of insulin receptor substrate-1, to enhance PI3K signalling,
again promoting neoplastic cell proliferation (Houghton et al., 2010).
Additionally Queen et al. as well as demonstrating a role for neutrophil-
derived oncostatin M in inducing breast cancer cell detachment and
invasion also highlighted its ability to trigger tumour cell proliferation
via activation of STAT3 (Queen et al., 2005). Neutrophil-derived
S100A8 and S100A9 have also been shown to promote tumour cell
survival and proliferation by activating MAPK signalling in metastatic
cells via RAGE, TLR-4, and carboxylated glycans which can also acti-
vate the NF-κB pathway (Acharyya et al., 2012; Ichikawa et al., 2011;
Yu et al., 2016).
In addition to providing tumour trophic factors, neutrophils are also
vital in supporting the formation of the pro-survival metastatic niche by
attracting other cells vital for the successful support of the metastatic
tumour cells. For example, Hirai et al. utilising murine metastasis
models of colon cancer showed that Ccl9 secreted by cancer cells re-
sulted in the early recruitment of Ccr1 expressing neutrophils into the
liver to surround metastatic foci (Hirai et al., 2014). In turn they
showed that this early recruitment of neutrophils was central to the
mechanisms driving the later accumulation of “monocyte/ﬁbrocytes”.
These “ﬁbrocytes” are so called because they express both monocytic
and mesenchymal markers including CD45+, and CD11b+ and vi-
mentin, and type I collagen respectively. In this study the two myeloid
populations, neutrophils and monocytic “ﬁbrocytes”, were shown to be
vital for the support of establishment and growth of liver metastases.
This requirement for neutrophils was due to their ability to attract the
monocytic “ﬁbrocytes” and produce MMP-9, and for “ﬁbrocytes” due to
their ability to produce of MMP-2 (Hirai et al., 2014).
Neutrophils have also been shown to be vital in driving metastatic
progression via inducing angiogenesis. If we consider the essential role
angiogenesis plays in primary tumours attempting to grow beyond
1–2mm3 it is perhaps unsurprising that growing metastases will come
under the same pressures and requirement for vascular supply (De
Palma et al., 2017). Numerous studies have highlighted the role that
neutrophils play in driving angiogenesis in the primary tumour (Bekes
et al., 2011; Deryugina et al., 2014; Jablonska et al., 2010; Li et al.,
2016; Shojaei et al., 2007). Whilst it is highly likely that similar me-
chanisms are at play in the metastatic niche, many of these mechanisms
are yet to be conﬁrmed. Some studies, however, are beginning to
conﬁrm a vital role for neutrophils in driving angiogenesis in the con-
text of metastasis (Gordon-Weeks et al., 2017; Lim et al., 2015). In
murine models of colorectal and pancreatic cancer metastasis, Gordon-
Weeks and colleagues have shown that neutrophil depletion sig-
niﬁcantly reduces microvessel density and vascular branching in me-
tastases and consequently inhibits their growth. FACS-sorted metas-
tasis-associated neutrophils expressed signiﬁcantly higher levels of
proangiogenic ﬁbroblast growth factor 2 (FGF2) but not VEGF, while
inhibition of FGF2 signalling resulted in a decrease in microvessel
density and vascular normalisation mirroring the exact eﬀect that of
neutrophil depletion in the same models (Gordon-Weeks et al., 2017).
Work from the same group has also previously shown that CD11b+
myeloid cells are able to support angiogenesis in metastases by down-
regulating antiangiogenic protein angiopoietin-like 7 (ANGPTL7) in
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colon and lung cancer cells. Indeed depletion of myeloid cells or
overexpression of ANGPTL7 in these models was associated with re-
duced hepatic metastasis and angiogenesis (Lim et al., 2015). Together,
the data suggest that tumour-mobilised neutrophils can induce a variety
of pro-metastatic eﬀects in distant sites.
3. Immunosuppression in the metastatic niche
As we have established, neutrophils are increasingly being proven to
play signiﬁcant roles in supporting the many stages of the metastatic
cascade. In addition to this they are also well known for their ability to
contribute to tumour survival through a multitude of im-
munosuppressive functions. Increasingly, these immunosuppressive
mechanisms are being shown to be vital in the outgrowth of metastatic
foci speciﬁcally. In our work we have shown that neutrophil depletion
in models of metastatic pancreatic ductal adenocarcinoma results in
increased T cell inﬁltration into both primary tumours and metastases
as well as an increased response to PD-1 inhibition (Steele et al., 2016).
Coﬀelt et al. elegantly showed in metastatic breast cancer models that
neutrophils are able to suppress cytotoxic CD8+ T cell function in the
early metastatic niche. In their models, IL-1β produced by macrophages
elicits IL-17 expression by gamma delta T cells, which in turn results in
a G-CSF-dependent increase in the number of cKIT+ neutrophils. These
neutrophils are vital to the successful establishment of metastasis due to
the production of iNOS and the suppression of the activation of CD8+ T
cells to CD62L−CD44+IFNgamma+ T cells (Coﬀelt et al., 2015). Indeed
neutrophils have been shown in melanoma patients to produce IL-10 in
response to the systemic acute phase protein serum amyloid A 1. Pro-
duced systemically and signalling through the G-protein coupled re-
ceptor FPR2, SAA-1 results in neutrophils with an immunosuppressive
phenotype capable of suppressing T cell proliferation via this IL-10
signalling. In these same patients it was also noted that the frequency of
these neutrophils in the peripheral blood correlated with disease stage
(De Santo et al., 2011). More recently, Wang and colleagues showed
that neutrophils isolated from pre-metastatic livers were able to pro-
foundly inhibit the proliferation and functional production of IFNγ by
cytotoxic CD8+ T cells in models of colorectal cancer metastasis (Wang
et al., 2017). Reduction of neutrophil inﬁltration into metastases via
deletion of TNF receptor-2 has also been shown to correlate with re-
duced CD4+FoxP3+ regulatory T cells within the metastatic niche
(Ham et al., 2015).
Interestingly, although all of the studies mentioned above show that
neutrophils are capable of altering T cell dynamics within the primary
tumour and metastatic context, none deﬁnitively conﬁrm the location
in which they are fulﬁlling this role. Given the central role of secondary
lymphoid organs and tertiary lymphoid structures in activating and
educating both B and T lymphocytes it is quite possible that neutrophils
may be enacting their immunosuppressive roles in these locations.
Again small numbers of studies are beginning to perhaps suggest that
this may well be the case. One such study showed that neutrophils
within liver metastases are able to inhibit the expression of CD80 on
hepatic B cells by inhibiting STAT3 activation via a contact-dependent
mechanism (Thorn et al., 2014). Given that B cells have the capacity to
perform as antigen presenting cells (APCs) it is noteworthy that their
expression of the vital co-stimulatory molecule CD80 is being prevented
in this context. In so doing, neutrophils are likely compromising the
ability of B cells as APCs within secondary lymphoid organs to stimulate
adaptive immune responses. Indeed in this study B cells with down-
regulated CD80 expression were unable to induce CD4+ T cell pro-
liferation in vitro. Interestingly, neutrophils themselves are now be-
lieved to be able to function as APCs, in addition to their ability to
inﬂuence the function of other APC populations (Singhal et al., 2016).
Ban et al. have shown that Ccl5 signalling in murine models of breast
cancer results in the generation of Ly6G+/MHCII+ cells with low levels
of CD86. CD86, similarly to CD80, is a co-stimulatory molecule ex-
pressed by APCs vital for the activation of adaptive immune responses.
Therefore, its absence in this context also correlates well with the
ﬁnding of reduced tumour-inﬁltrating CD8+ T cells and increased
regulatory T cells within lymph nodes in these models. Importantly,
inhibition of Ccl5 signalling resulted in the increased expression of
CD86 by these neutrophils functioning as APCs and was associated with
the inﬂux of CD8+ T cells into tumours and a reduction in the number
of regulatory T cells within draining lymph nodes (Ban et al., 2017).
Intriguingly inhibition of CCL5 signalling has been previously predicted
to prevent metastasis (Capece et al., 2012).
In addition to altering T cell dynamics, neutrophils have been
shown to modulate the innate immune response in the premetastatic
niche through the inhibition of NK cell cytotoxic responses (Sceneay
et al., 2012; Spiegel et al., 2016). As highlighted previously, Spiegel and
colleagues demonstrated a vital role for neutrophils in preventing early
NK cell killing of metastatic cells within the pulmonary vasculature,
while an earlier, study also demonstrated that neutrophils within the
premetastatic niche have the capacity to suppress NK cell cytotoxicity
(Sceneay et al., 2012). Thus, targeting the immuno-suppressive signals
that emanate from pro-tumourigenic neutrophils could provide oppor-
tunities for targeted therapy or immunotherapy that may have eﬃcacy
in both the primary tumour and distant sites.
4. Conclusions
Neutrophils are increasingly emerging as major cellular mediators
that play signiﬁcant roles at all stages of tumorigenesis and all steps of
the metastatic cascade. These roles, as highlighted in this review, are
mainly pro-tumoural, however, this is not exclusively the case. Indeed,
whilst the majority of the literature points to a pro-tumoural role for
neutrophils, it has also been shown in a small number of studies that
neutrophils may promote tumour cell killing and prevent metastatic
establishment (Granot et al., 2011). As alluded to in the introduction of
this paper the variable role that neutrophils play is unsurprising given
the ability of granulocytic myeloid cells to express such a wide and
diverse spectrum of phenotypes. This spectrum of phenotypes and their
context dependency increasingly necessitates the need to more com-
pletely understand the network of complementary and antagonistic
factors controlling neutrophil development, polarisation, and activation
both during granulopoiesis and within the peripheral circulation and
tissues. Given the diverse range of eﬀects neutrophils have been found
to have it is unlikely that the simple depletion of neutrophils will have
signiﬁcant therapeutic beneﬁt. Finally, as eloquently voiced by a
number of recent reviews, the requirement for literature to more con-
sistently, accurately, and precisely deﬁne granulocytic myeloid cell
populations of interest beyond CD11b+Gr1+ will be central to un-
ravelling the importance of neutrophils in cancer and metastasis
(Coﬀelt et al., 2016; Mishalian et al., 2017). Indeed CD11b+, Ly6G+,
cellular density, and nuclear morphology should/could perhaps be
considered a minimum panel.
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Glossary
Metastatic niche: The (pre)-metastatic niche refers to the site in a distant organ that can be
colonised by tumour cells. the microenvironment of the niche provides a supportive
environment for the tumour cells to survive and grow in what would normally be
hostile alien conditions.
Invasion: The active inﬁltration by cancer cells into neighbouring healthy tissue.
Angiogenic Switch: The stage at which a pre-vascular mass of tumour cells becomes vas-
cularised through neo-angiogenesis (the growth of new blood vessels), enabling
supply of oxygen and essential nutrients and the continued growth of the tumour.
Intravasation: The process by which cells enter the bloodstream.
Extravasation: The process by which cells exit the bloodstream.
Immunotherapy: Therapy designed to harness the host immune system to ﬁght cancer,
either by blocking immune checkpoints, or by engineering host t cells to speciﬁcally
recognize tumour cells.
J. Leach et al. Molecular Immunology xxx (xxxx) xxx–xxx
8
